Search research articles
Contact Us
Filters
Showing results (171-180 of 181) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 2010
Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1
S Bonetti, M Trombetta, G Malerba, et al.
Diabetologia
|
June 1, 1996
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group
S Kumar, A J Boulton, H Beck-Nielsen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
November 1, 1996
Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study
E Bonora, G Targher, M B Zenere, et al.
European Journal of Clinical Investigation
|
March 1, 1997
Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study
E Bonora, G Targher, M B Zenere, et al.
European Journal of Clinical Investigation
|
May 31, 2001
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion
A Cretti, M Lehtovirta, E Bonora, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 11, 2001
ACE genotype and endothelium-dependent vasodilation of conduit arteries and forearm microcirculation in humans
G Arcaro, A Solini, T Monauni, et al.
Diabetes
|
June 24, 2000
Effects of glucosamine infusion on insulin secretion and insulin action in humans
T Monauni, M G Zenti, A Cretti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 7, 2004
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
E Bonora, G Targher, G Formentini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 9, 2002
Predictors of insulin sensitivity in Type 2 diabetes mellitus
E Bonora, G Targher, M Alberiche, et al.
Diabetes, Nutrition & Metabolism
|
December 4, 2004
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ)
A Nicolucci, R Giorgino, D Cucinotta, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 181) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Endocrinology and Metabolism
|
December 17, 2010
Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1
S Bonetti, M Trombetta, G Malerba, et al.
Diabetologia
|
June 1, 1996
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group
S Kumar, A J Boulton, H Beck-Nielsen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
November 1, 1996
Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study
E Bonora, G Targher, M B Zenere, et al.
European Journal of Clinical Investigation
|
March 1, 1997
Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study
E Bonora, G Targher, M B Zenere, et al.
European Journal of Clinical Investigation
|
May 31, 2001
Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion
A Cretti, M Lehtovirta, E Bonora, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 11, 2001
ACE genotype and endothelium-dependent vasodilation of conduit arteries and forearm microcirculation in humans
G Arcaro, A Solini, T Monauni, et al.
Diabetes
|
June 24, 2000
Effects of glucosamine infusion on insulin secretion and insulin action in humans
T Monauni, M G Zenti, A Cretti, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 7, 2004
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
E Bonora, G Targher, G Formentini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 9, 2002
Predictors of insulin sensitivity in Type 2 diabetes mellitus
E Bonora, G Targher, M Alberiche, et al.
Diabetes, Nutrition & Metabolism
|
December 4, 2004
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ)
A Nicolucci, R Giorgino, D Cucinotta, et al.
Page
of 19